Financial Advocates Investment Management »

G1 Therapeutics shares owned by Financial Advocates Investment Management

Quarter-by-quarter ownership of G1 Therapeutics (GTHX) shares owned by Financial Advocates Investment Management from 13F filings

Historical chart of Financial Advocates Investment Management investment in G1 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including G1 Therapeutics held by Financial Advocates Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in G1 Therapeutics by Financial Advocates Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $62k 15k 4.32
2023-12-31 $40k 13k 3.05

More positions owned by Financial Advocates Investment Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Apple Put Option (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation Put Option (NVDA)
Vanguard Index Fds Growth Etf (VUG)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon Put Option (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Core Us Aggbd Et (AGG)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Ishares Tr S&p 500 Grwt Etf (IVW)
Vanguard Scottsdale Fds Total Corp Bnd (VTC)

View all positions for Financial Advocates Investment Management

Top funds holding G1 Therapeutics

Vanguard Group
Raymond James & Associates
D. E. Shaw & Co
Standard Life Aberdeen
Marshall Wace
Schonfeld Strategic Advisors
Jacobs Levy Equity Management
Bank of America Corporation
Jane Street
Connor, Clark & Lunn Investment Management
Level Four Advisory Services
Two Sigma Investments
Man Group
Citadel Advisors
Two Sigma Advisers

View all funds holding G1 Therapeutics